Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Alopecia areata affects quality of life more in adolescents than adults.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Pexidartinib often causes liver issues and fatigue, especially in women.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Various treatments exist for hair loss, but more research is needed for better options.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Microneedling can effectively promote hair regrowth in alopecia areata.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

Baricitinib is an effective treatment for severe alopecia areata.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

These gene variations are not linked to alopecia areata in Egyptians.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Current treatments for alopecia show no significant long-term benefits.